IOVA Q1 2020 Earnings — Iovance Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

IOVAIovance Biotherapeutics, Inc.

$2B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$71M

Net Income

-$70M

EPS (Diluted)

$-0.55

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$65M

Free Cash Flow

-$66M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$288M

Total Liabilities

$45M

Stockholders' Equity

$243M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$71M	-$40M	-77.1%
Net Income	-$70M	-$37M	-88.3%